Local real estate design and construction firm Singpoli Capital Corporation has spearheaded the launch of a new Chinese language web site for horse race betting online beginning Dec. 26.
Singpoli, with offices in Arcadia and Pasadena, introduced YUPRacing.com on Tuesday, Dec. 10, a partnership with Santa Anita Park track owner The Stonach Group’s Xpressbet LLC, one of the largest multi-jurisdictional simulcasting and interactive advance deposit wagering providers in North America. YUPRacing is aimed at providing the Chinese-American community with a wagering platform and news/entertainment outlet dedicated to horseracing.
“Horseracing and horserace wagering are extremely popular with the Chinese-American community in Southern California; yet, this population has largely been underserved mainly due to language barriers and cultural gaps,” said Mr. Kin Hui, CEO of Singpoli Capital Corporation. “YUPRacing.com, a web platform in simplified and traditional Chinese, will provide access for this community to learn about horseracing, get the latest news and entertainment, and place legalized wagers on the platform, which is powered by Xpressbet, LLC,” he continued.
YUPRacing.com will provide dynamic content in the areas of current racing news; information about race tracks; feature stories and videos covering significant races, horses, jockeys and trainers; a wagering platform; and YUP Racing Club, a membership club providing horseracing-centric networking, events and incentives to the community.
Wagering on YUPRacing.com will be available starting the first day of the new racing season at Santa Anita Park on December 26. YUP Racing will also be accessible on mobile devices in early 2014.
Singpoli is a real estate company specializing in architecture, design, development, investment, construction, brokerage, asset management and finance. In addition, Singpoli also runs a successful media company, is active in the local community by supporting art and charitable organizations, and invests in innovation projects and cutting-edge medical research.
— By Scott Hettrick